心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

慢性心力衰竭患者的心率管理策略

2017-10-30 中国循证心血管医学杂志.2017,9(10):1153-1155.

心力衰竭

2016 ESC心衰指南中对心衰患者的心率管理策略作出了进一步的推荐。本文结合该指南建议，从心衰患者心率控制的意义，心率管理的目标，以及心率管理手段方法等方面进一步阐释解读。

中文标题：

慢性心力衰竭患者的心率管理策略

发布机构：

发布日期：

2017-10-30

简要介绍：

2016 ESC心衰指南中对心衰患者的心率管理策略作出了进一步的推荐。本文结合该指南建议，从心衰患者心率控制的意义，心率管理的目标，以及心率管理手段方法等方面进一步阐释解读。

作者： 青海省人民医院心血管内科 吴金春 常荣

 

拓展指南：与心力衰竭相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=慢性心力衰竭患者的心率管理策略)] GetToolGuiderByIdResponse(projectId=1, id=750351c001556ebc, title=慢性心力衰竭患者的心率管理策略, enTitle=, guiderFrom=中国循证心血管医学杂志.2017,9(10):1153-1155., authorId=null, author=, summary=2016 ESC心衰指南中对心衰患者的心率管理策略作出了进一步的推荐。本文结合该指南建议，从心衰患者心率控制的意义，心率管理的目标，以及心率管理手段方法等方面进一步阐释解读。 , cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Mon Oct 30 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>2016 ESC心衰指南中对心衰患者的心率管理策略作出了进一步的推荐。本文结合该指南建议，从心衰患者心率控制的意义，心率管理的目标，以及心率管理手段方法等方面进一步阐释解读。 </P>作者： 青海省人民医院心血管内科 吴金春 常荣 <P> </P>拓展指南：<strong>与<font color=red>心力衰竭</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=346b51c00152e883" title="中国急性心力衰竭急诊临床实践指南（2017）" target=_blank>中国急性心力衰竭急诊临床实践指南（2017）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=986481c001519690" title="2017 CCS指南：心力衰竭的管理（全面更新）" target=_blank>2017 CCS指南：心力衰竭的管理（全面更新）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=bb75e1c001a949de" title="2017 ACC/AHA/HFSA心力衰竭管理指南更新解读" target=_blank>2017 ACC/AHA/HFSA心力衰竭管理指南更新解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=2e3641c001ae3221" title="基层医院心力衰竭临床诊疗中B型利钠肽和N末端B型利钠肽原的应用中国专家建议" target=_blank>基层医院心力衰竭临床诊疗中B型利钠肽和N末端B型利钠肽原的应用中国专家建议</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=9a0cf1c001a684db" title="从指南到临床—再读2017ACC/AHA/HFSA心力衰竭处理指南" target=_blank>从指南到临床—再读2017ACC/AHA/HFSA心力衰竭处理指南</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E5%BF%83%E5%8A%9B%E8%A1%B0%E7%AB%AD" target=_blank>有关心力衰竭更多指南</a></ul>, tagList=[TagDto(tagId=335, tagName=心力衰竭)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5093, appHits=532, showAppHits=0, pcHits=3555, showPcHits=1475, likes=145, shares=13, comments=17, approvalStatus=1, publishedTime=Sun Feb 18 21:39:58 CST 2018, publishedTimeString=2017-10-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Feb 18 21:39:58 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 13:12:40 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=慢性心力衰竭患者的心率管理策略)])
慢性心力衰竭患者的心率管理策略
下载请点击：
评论区 (17)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=883559, encodeId=d6b988355943, content=1, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Tue Sep 08 10:48:47 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289343, encodeId=d12b28934311, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Tue Feb 20 07:35:01 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289139, encodeId=7f8e28913966, content=好好学习天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Feb 19 09:40:07 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289129, encodeId=6bb6289129e8, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Feb 19 09:22:31 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289110, encodeId=9e0f2891106a, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Feb 19 08:20:27 CST 2018, time=2018-02-19, status=1, ipAttribution=)]
    2020-09-08 ms1000000302953060

    1

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=883559, encodeId=d6b988355943, content=1, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Tue Sep 08 10:48:47 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289343, encodeId=d12b28934311, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Tue Feb 20 07:35:01 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289139, encodeId=7f8e28913966, content=好好学习天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Feb 19 09:40:07 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289129, encodeId=6bb6289129e8, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Feb 19 09:22:31 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289110, encodeId=9e0f2891106a, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Feb 19 08:20:27 CST 2018, time=2018-02-19, status=1, ipAttribution=)]
    2018-02-20 一个字-牛

    学习了谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=883559, encodeId=d6b988355943, content=1, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Tue Sep 08 10:48:47 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289343, encodeId=d12b28934311, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Tue Feb 20 07:35:01 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289139, encodeId=7f8e28913966, content=好好学习天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Feb 19 09:40:07 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289129, encodeId=6bb6289129e8, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Feb 19 09:22:31 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289110, encodeId=9e0f2891106a, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Feb 19 08:20:27 CST 2018, time=2018-02-19, status=1, ipAttribution=)]
    2018-02-19 忠诚向上

    好好学习天天向上

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=883559, encodeId=d6b988355943, content=1, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Tue Sep 08 10:48:47 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289343, encodeId=d12b28934311, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Tue Feb 20 07:35:01 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289139, encodeId=7f8e28913966, content=好好学习天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Feb 19 09:40:07 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289129, encodeId=6bb6289129e8, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Feb 19 09:22:31 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289110, encodeId=9e0f2891106a, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Feb 19 08:20:27 CST 2018, time=2018-02-19, status=1, ipAttribution=)]
    2018-02-19 1dd8c52fm63(暂无匿称)

    了解了解.学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=883559, encodeId=d6b988355943, content=1, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Tue Sep 08 10:48:47 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289343, encodeId=d12b28934311, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Tue Feb 20 07:35:01 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289139, encodeId=7f8e28913966, content=好好学习天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Feb 19 09:40:07 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289129, encodeId=6bb6289129e8, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Feb 19 09:22:31 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289110, encodeId=9e0f2891106a, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Feb 19 08:20:27 CST 2018, time=2018-02-19, status=1, ipAttribution=)]
    2018-02-19 yjs木玉

    好好好好好好好好

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2017 CCS指南：心力衰竭的管理（全面更新）

加拿大心血管学会(CCS,Canadian Cardiovascular Society) · 2017-11-03

2017 ACC/AHA/HFSA心力衰竭管理指南更新解读

暂未更新 · 2017-09-04

基层医院心力衰竭临床诊疗中B型利钠肽和N末端B型利钠肽原的应用中国专家建议

中国心血管相关专家小组（统称） · 2017-03-20

从指南到临床—再读2017ACC/AHA/HFSA心力衰竭处理指南

暂未更新 · 2017-07-03

ESC2016指南建议：伊伐布雷定在心力衰竭治疗中的作用

欧洲心脏病学会(ESC,European Society of Cardiology) · 2017-04-26

2017 ACC/AHA/HFSA指南：心力衰竭的管理（更新版）

暂未更新 · 2017-04-28